V Square Quantitative Management LLC Sells 6,605 Shares of CVS Health Corporation $CVS

V Square Quantitative Management LLC lowered its stake in shares of CVS Health Corporation (NYSE:CVS) by 38.7% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 10,475 shares of the pharmacy operator’s stock after selling 6,605 shares during the quarter. V Square Quantitative Management LLC’s holdings in CVS Health were worth $723,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently bought and sold shares of the stock. Sound Income Strategies LLC increased its holdings in shares of CVS Health by 32.3% during the 2nd quarter. Sound Income Strategies LLC now owns 2,774 shares of the pharmacy operator’s stock worth $191,000 after purchasing an additional 677 shares during the period. Smith Salley Wealth Management increased its stake in CVS Health by 3.2% during the second quarter. Smith Salley Wealth Management now owns 9,002 shares of the pharmacy operator’s stock valued at $621,000 after acquiring an additional 275 shares during the period. San Luis Wealth Advisors LLC acquired a new position in CVS Health in the 2nd quarter valued at approximately $674,000. Patton Albertson Miller Group LLC lifted its position in shares of CVS Health by 5.8% in the 2nd quarter. Patton Albertson Miller Group LLC now owns 17,228 shares of the pharmacy operator’s stock worth $1,188,000 after acquiring an additional 940 shares during the period. Finally, Guyasuta Investment Advisors Inc. grew its holdings in shares of CVS Health by 39.3% during the 2nd quarter. Guyasuta Investment Advisors Inc. now owns 4,713 shares of the pharmacy operator’s stock worth $325,000 after purchasing an additional 1,330 shares in the last quarter. 80.66% of the stock is owned by institutional investors.

Analyst Ratings Changes

CVS has been the subject of several research reports. Jefferies Financial Group raised their target price on CVS Health from $74.00 to $80.00 and gave the stock a “buy” rating in a research report on Monday, June 30th. Bernstein Bank reduced their price objective on shares of CVS Health from $78.00 to $72.00 and set a “market perform” rating for the company in a report on Wednesday, July 16th. Robert W. Baird raised shares of CVS Health from a “neutral” rating to an “outperform” rating and upped their target price for the company from $71.00 to $82.00 in a research note on Thursday, August 14th. Cowen restated a “buy” rating on shares of CVS Health in a research note on Monday, August 4th. Finally, Baird R W raised CVS Health from a “hold” rating to a “strong-buy” rating in a report on Thursday, August 14th. Two investment analysts have rated the stock with a Strong Buy rating, nineteen have given a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $78.25.

Insider Buying and Selling at CVS Health

In related news, Director Anne A. Finucane sold 7,500 shares of the firm’s stock in a transaction that occurred on Wednesday, August 20th. The shares were sold at an average price of $71.02, for a total value of $532,650.00. Following the completion of the sale, the director owned 22,156 shares of the company’s stock, valued at $1,573,519.12. This trade represents a 25.29% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Corporate insiders own 1.22% of the company’s stock.

CVS Health Stock Down 0.3%

Shares of CVS opened at $75.52 on Tuesday. The business’s 50 day simple moving average is $69.41 and its 200-day simple moving average is $67.07. CVS Health Corporation has a one year low of $43.56 and a one year high of $77.34. The company has a market capitalization of $95.78 billion, a P/E ratio of 21.10, a PEG ratio of 0.84 and a beta of 0.62. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.80 and a quick ratio of 0.62.

CVS Health (NYSE:CVS) last issued its quarterly earnings data on Thursday, July 31st. The pharmacy operator reported $1.81 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.46 by $0.35. The firm had revenue of $98.92 billion during the quarter, compared to the consensus estimate of $94.87 billion. CVS Health had a return on equity of 10.51% and a net margin of 1.17%.The business’s revenue for the quarter was up 8.4% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.83 EPS. CVS Health has set its FY 2025 guidance at 6.300-6.400 EPS. As a group, sell-side analysts predict that CVS Health Corporation will post 5.89 EPS for the current fiscal year.

CVS Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Monday, November 3rd. Shareholders of record on Thursday, October 23rd will be given a $0.665 dividend. This represents a $2.66 annualized dividend and a yield of 3.5%. The ex-dividend date is Thursday, October 23rd. CVS Health’s dividend payout ratio (DPR) is presently 74.30%.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.